Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N
ANIP.OQ - ANI Pharmaceuticals Inc
ANI Pharmaceuticals Inc at H.C. Wainwright BioConnect Investor Conference
May 02, 2023 / 04:00PM GMT
=====================
Conference Call Participants
=====================
* Oren Livnat
H.C. Wainwright BioConnect - specialty pharmaceuticals analyst
* Nikhil Lalwani
ANI Pharmaceuticals - CEO
=====================
Presentation
--------------------------------------------------------------------------------
Oren Livnat, H.C. Wainwright BioConnect - specialty pharmaceuticals analyst [1]
--------------------------------------------------------------------------------
And to the HC. Wainwright Biocon's investor conference at NASDAQ. My name is Oren Livnat on specialty pharmaceuticals analyst here at H.C. Wainwright. And it's my pleasure to welcome our next presenter, ANI Pharmaceuticals. And with us today is CEO, Nikhil Lalwani.
And I as a leader in specialty and limited competition generics in the US and it's recently diversified into rare disease with